-
All Events
IAO-EAO-SIdP joint meeting 2024EAO-DGI joint meeting 202329th Annual Scientific CongressEAO Digital Days 2021EAO Digital Days 202028th Annual Scientific Congress27th Annual Scientific Congress26th Annual Scientific Congress25th Annual Scientific Congress24th Annual Scientific Congress23rd Annual Scientific Congress -
All Content TypesAbstractArticle ReviewePosterLearning moduleLearning QuizMatching SlidePDF DocumentWebcast
-
Sort ByRelevance
Protected by US Patents
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
The following report summarises the second paper presented during the Successful supportive treatment - evidence for clinical efficacy session, at the EAO's 24th annual Scientific Meeting in Stockholm, 2015.
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
Supportive therapy following treatment of peri-implant disease
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The following report summarises the second paper presented during the Successful supportive treatment - evidence for clinical efficacy session, at the EAO's 24th annual Scientific Meeting in Stockholm, 2015.
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
Supportive therapy following treatment of peri-implant disease
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
Supportive therapy following treatment of peri-implant disease
Prof. Lisa Heitz-Mayfield
Abstract
Discussion Forum (0)
The following report summarises the second paper presented during the Successful supportive treatment - evidence for clinical efficacy session, at the EAO's 24th annual Scientific Meeting in Stockholm, 2015.
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
Supportive therapy following treatment of peri-implant disease
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The following report summarises the second paper presented during the Successful supportive treatment - evidence for clinical efficacy session, at the EAO's 24th annual Scientific Meeting in Stockholm, 2015.
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
The clinical outcome of implant treatment has to be judged over the long-term, with the main objective of success being benefit to the patient. With this in mind, it is disturbing that levels of peri-implant inflammation appear to be extremely high. This has the potential to become a significant area of concern for public health in the growing population that has been treated with dental implants.
Addressing this problem will involve developing standardised supportive treatment that can be applied universally. At the moment, this approach seems to offer the only effective way of preventing the biological problems that have been associated with oral osseointegration.
This session described some of the available evidence relating to this serious problem:
- Hugo De Bruyn provided a comprehensive update on peri-implantitis, including its diagnosis, prevalence and preventive measures for each of the factors involved
- Lisa Heitz-Mayfield discussed the practical steps involved in supportive care for implant patients. Evidence for the efficacy of supportive peri-implant therapy following treatment of peri-implant disease was also presented
- Mariano Sanz focused on the options available to prevent these problems from occurring, looking at the issue from primary, secondary and tertiary perspectives
Supportive therapy following treatment of peri-implant disease
The speaker began with an overview about supportive therapy, including its goals; the recommended frequency and protocols; the supporting evidence; and patient compliance.
Even though it has been well documented through comparative studies that the absence of maintenance (a lack of patient compliance and poor plaque control) is associated with a high incidence of peri-implantitis, an acceptable standard of supportive therapy is rarely described. Few studies include an in-depth description of the protocol for supportive therapy used in their materials and methods, despite the fact that this is a key factor to long-term success. The speaker reviewed the most relevant studies addressing supportive therapy and 5-year implant outcomes and presented studies that followed patients receiving supportive therapy following treatment of peri-implantitis.
Compliance with supportive therapy is an important factor in achieving good long-term results. It has been correlated with lower complication rates, especially if the patient had a previous history of periodontitis.
The recommended protocol for supportive therapy for patients who have been treated for peri-implant disease consists of four steps:
1. Examination, re-evaluation and diagnosis
2. Motivation, re-instruction and instrumentation
3. Treatment of re-infected sites
4. Risk assessment
Having completed these steps the recall interval should be determined. The periodontal risk assessment is a useful tool for establishing the recall frequency and is available for download from the University of Bern website www.perio-tools.com.
This summary was prepared by the EAO Congress Scientific Report rapporteurs.
View the full publication at: www.eao.org
{{ help_message }}
{{filter}}